FI901903A0 - Antivirala aemnen. - Google Patents

Antivirala aemnen.

Info

Publication number
FI901903A0
FI901903A0 FI901903A FI901903A FI901903A0 FI 901903 A0 FI901903 A0 FI 901903A0 FI 901903 A FI901903 A FI 901903A FI 901903 A FI901903 A FI 901903A FI 901903 A0 FI901903 A0 FI 901903A0
Authority
FI
Finland
Prior art keywords
antivirala
aemnen
sugar
nucleoside
analogue
Prior art date
Application number
FI901903A
Other languages
English (en)
Finnish (fi)
Inventor
David Frederick Horrobin
John Charles Marshall Stewart
Michael David Winther
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908646A external-priority patent/GB8908646D0/en
Priority claimed from GB898921266A external-priority patent/GB8921266D0/en
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of FI901903A0 publication Critical patent/FI901903A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI901903A 1989-04-17 1990-04-12 Antivirala aemnen. FI901903A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898908646A GB8908646D0 (en) 1989-04-17 1989-04-17 Anti-viral agents
GB898921266A GB8921266D0 (en) 1989-09-20 1989-09-20 Anti-viral agents

Publications (1)

Publication Number Publication Date
FI901903A0 true FI901903A0 (fi) 1990-04-12

Family

ID=26295232

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901903A FI901903A0 (fi) 1989-04-17 1990-04-12 Antivirala aemnen.

Country Status (16)

Country Link
US (2) US5216142A (ko)
EP (2) EP0693498A1 (ko)
JP (1) JP2952505B2 (ko)
KR (1) KR100188616B1 (ko)
AT (1) ATE155142T1 (ko)
AU (1) AU637362B2 (ko)
CA (1) CA2014662C (ko)
DE (1) DE69031007T2 (ko)
DK (1) DK0393920T3 (ko)
ES (1) ES2108686T3 (ko)
FI (1) FI901903A0 (ko)
GR (1) GR3024835T3 (ko)
HK (1) HK1001003A1 (ko)
IE (1) IE980216A1 (ko)
NZ (1) NZ233297A (ko)
TW (1) TW215417B (ko)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals
US5459255A (en) * 1990-01-11 1995-10-17 Isis Pharmaceuticals, Inc. N-2 substituted purines
CA2073500C (en) * 1990-01-11 2008-03-25 Phillip Dan Cook Compositions and methods for detecting and modulating rna activity and gene expression
US6262241B1 (en) * 1990-08-13 2001-07-17 Isis Pharmaceuticals, Inc. Compound for detecting and modulating RNA activity and gene expression
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
EP0823897B1 (en) * 1995-05-01 2004-07-28 Scarista Limited Nicotinic acid esters and pharmaceutical compositions containing them
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
US5639460A (en) * 1995-06-07 1997-06-17 Raymond; Hal C. Aqueous plant extract having antiviral activity
US5840711A (en) * 1995-06-21 1998-11-24 University Of Kentucky Research Foundation Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US6673784B1 (en) * 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
AU1940897A (en) * 1996-03-28 1997-10-17 Shionogi & Co., Ltd. Lymph-absorbable imidazole derivatives
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU1412299A (en) * 1997-11-25 1999-06-15 Protarga, Inc. Nucleoside analog compositions and uses thereof
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
US5977174A (en) * 1997-11-26 1999-11-02 Neuromedica, Inc. Cholinergic compositions and uses thereof
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
US6153653A (en) * 1997-11-26 2000-11-28 Protarga, Inc. Choline compositions and uses thereof
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
WO2000016625A1 (en) * 1998-09-23 2000-03-30 University Of Kentucky Research Foundation Antiviral drug compositions containing lithium inorganic salts
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
AU2002303164A1 (en) * 2001-03-23 2002-10-08 Protarga, Inc. Fatty amine drug conjugates
JP4634694B2 (ja) * 2001-03-23 2011-02-16 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪アルコール薬物複合体
US20060122174A1 (en) * 2001-09-21 2006-06-08 Henderson Morley Research & Development Limited Antiviral treatment
EP1436006A4 (en) * 2001-10-16 2006-06-07 Avanir Pharmaceuticals VIRAL INHIBITION BY N-DOCOSANOL
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
AU2003296601A1 (en) * 2002-12-10 2004-06-30 F. Hoffmann-La Roche Ag Antiviral nucleoside derivatives
EP1722630A4 (en) * 2004-01-20 2009-05-27 Richard F Harty COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES
NO324263B1 (no) 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US20090111774A1 (en) * 2007-06-01 2009-04-30 Luitpold Pharmaceuticals, Inc. Pmea lipid conjugates
CN101835374B (zh) 2007-07-09 2014-08-27 东弗吉尼亚医学院 具有抗病毒和抗微生物性质的取代的核苷衍生物
UA99836C2 (en) 2007-09-26 2012-10-10 Маунт Синай Скул Оф Медсин Azacytidine analogue and using thereof
US10463684B2 (en) 2014-01-29 2019-11-05 Board Of Regents, The Uneversety Of Texas System Nucleobase analogue derivatives and their applications

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2354288C2 (de) * 1973-10-30 1976-01-02 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von Aminophenylalkyläthern
JPS5126883A (en) * 1974-08-22 1976-03-05 Asahi Chemical Ind N44 ashiru shichijinno seiho
JPS5132573A (en) * 1974-09-11 1976-03-19 Asahi Chemical Ind Nn ashiruarabinonukureoshido no seizohoho
US4340728A (en) * 1979-11-28 1982-07-20 Fuji Kagaku Kogyo Kabushiki Kaisha Nucleoside derivatives and process for preparing same
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
JPS5813394A (ja) * 1981-07-17 1983-01-25 Ajinomoto Co Inc １−β−Ｄ−リボフラノシル−４，５−置換イミダゾ−ルの製造法
EP0082668A1 (en) * 1981-12-18 1983-06-29 Beecham Group Plc 5-(2-Halogenovinyl)-2'-deoxyuridine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in treating viral infections
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
IL72173A0 (en) * 1983-06-24 1984-10-31 Merck & Co Inc Guanine derivatives,their preparation and pharmaceutical compositions containing them
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
JPS6144897A (ja) * 1984-08-10 1986-03-04 Terumo Corp ５−フルオロウラシル誘導体およびこれを含有する医薬製剤
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
DE3650492T2 (de) * 1985-03-16 1996-10-31 The Wellcome Foundation Ltd., London Therapeutische Nukleoside
IT1188654B (it) * 1985-04-15 1988-01-20 Toyo Jozo Kk Coniugato nucleo side-fosfolipide
DE3650741T2 (de) * 1985-09-17 2000-10-12 The Wellcome Foundation Ltd., Greenford Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
DE3778626D1 (de) * 1986-09-27 1992-06-04 Toyo Jozo Kk Nukleosid-phospholipid-konjugat.
DE3883374T2 (de) * 1987-10-28 1993-12-09 Pro Neuron Inc Acylatiertes uridin und cytidin und deren verwendungen.
CA1329932C (en) * 1987-10-28 1994-05-31 Reid Von Borstel Acyl deoxyribonucleoside derivatives and uses thereof
IE980216A1 (en) * 1989-04-17 2000-02-23 Scotia Holdings Plc Anti-virals

Also Published As

Publication number Publication date
CA2014662C (en) 2002-09-17
US5276020A (en) 1994-01-04
JP2952505B2 (ja) 1999-09-27
DE69031007T2 (de) 1997-12-04
TW215417B (ko) 1993-11-01
DK0393920T3 (da) 1997-09-22
EP0393920A3 (en) 1991-07-03
IE980216A1 (en) 2000-02-23
GR3024835T3 (en) 1998-01-30
ATE155142T1 (de) 1997-07-15
CA2014662A1 (en) 1990-10-17
AU5329090A (en) 1990-10-18
EP0393920A2 (en) 1990-10-24
HK1001003A1 (en) 1998-05-15
JPH02304084A (ja) 1990-12-17
AU637362B2 (en) 1993-05-27
ES2108686T3 (es) 1998-01-01
EP0393920B1 (en) 1997-07-09
US5216142A (en) 1993-06-01
KR100188616B1 (ko) 1999-06-01
KR900015742A (ko) 1990-11-10
DE69031007D1 (de) 1997-08-14
NZ233297A (en) 1997-07-27
EP0693498A1 (en) 1996-01-24

Similar Documents

Publication Publication Date Title
FI901903A0 (fi) Antivirala aemnen.
BR8805598A (pt) Instrumento de projeto conceitual
DE68929071D1 (de) Selbstabtastende Anordnung von lichtemittierenden Bauelementen
DE3864333D1 (de) Baukastenprinzip fuer ein triebwerk.
DK179388D0 (da) Acylderivater
ES2043012T3 (es) Derivados de carboxamidas aromaticas y heterociclicas como agentes antineoplasticos.
MC1879A1 (fr) Derives de la pyridazodiazepine
MC1970A1 (fr) Derives acyles
FR2639044B1 (fr) Derives de la butynylamine
MC1916A1 (fr) Derives de propiolophenone
DK667188D0 (da) Psykotrope acycliske amidderivater
DK278688A (da) Anf-derivater
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
MC1934A1 (fr) Derives de pyrimidine
DE69015463D1 (de) Elektronisches Endoskop zur Beobachtung eines mittels Laserlicht beleuchteten Körperteils.
DE68901401D1 (de) Analogzeitgebende vorrichtung.
FI930797A (fi) Insektbestaendig formkropp anvaendbar i lantbruksbyggnader
DE69127303D1 (de) Substituierte Triazolopyridazine
MC2000A1 (fr) Derives acyles
FR2608751B1 (fr) Chaine de mesure dimensionnelle capacitive
DE3854064D1 (de) Hydrochinonylphenyl-Buttersäureamid-Derivate.
DE68901163D1 (de) Vorrichtung zur befestigung eines elementes auf der aussenseite eines hohlkoerpers.
SE8703363D0 (sv) Anordning for registrering av metdata i en brunn till en gas- eller oljekella
ES555543A0 (es) Procedimiento para el ulterior curtido de cuero al cromo
ES1003163Y (es) Linea para montaje de carrocerias de vehiculos y partes fijas a las mismas.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: EFAMOL HOLDINGS PLC